Brief: Nrx Pharmaceuticals Announces Licensure Of A U.S. Patent To Support Use Of Nrx-101 For Chronic Pain
07/08/2023 15:44
Aug 7 (Reuters) - NRX Pharmaceuticals Inc NRXP.O :
* NRX PHARMACEUTICALS ANNOUNCES THE LICENSURE OF A US PATENT
TO
SUPPORT USE OF NRX-101™ FOR CHRONIC PAIN
Source text for Eikon: ID:nPn9J10DWa
Further company coverage: NRXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NRX Pharmaceuticals
See all newsBrief: NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024
U.S. RESEARCH ROUNDUP-Cintas Corp, Sprouts Farmers market, Voya Financial
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery
U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power
NRX Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview